A modified nanoparticle–mRNA complex for improved gene editing in the heart

a-modified-nanoparticle–mrna-complex-for-improved-gene-editing-in-the-heart
A modified nanoparticle–mRNA complex for improved gene editing in the heart
  • Research Briefing
  • Published:

Nature Biomedical Engineering (2025)Cite this article

Subjects

Lipid nanoparticle–mRNA complexes hold promise for treating cardiac diseases, but their transfection efficiency into the heart is limited. Using our previously developed human cardiac microphysiological screen, we identified modified lipid nanoparticle–mRNA complexes with improved transfection and gene editing efficacy, both in 3D micromuscles and in vivo in mice.

This is a preview of subscription content, access via your institution

Access options

Access Nature and 54 other Nature Portfolio journals

Get Nature+, our best-value online-access subscription

$32.99 / 30 days

cancel any time

Subscribe to this journal

Receive 12 digital issues and online access to articles

$119.00 per year

only $9.92 per issue

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Screening novel acid-degradable LNPs in a human cardiac MPS identifies LNPs that effectively deliver mRNA to dense 3D tissue.

References

  1. Tsao, C. W. et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation 145, e153–e639 (2022). A review article that presents how heart failure is the leading cause of death worldwide.

    Article  PubMed  Google Scholar 

  2. Wadman, M. FDA no longer has to require animal testing for new drugs. Science 379, 127–128 (2023). This communication reports that the FDA now has the authority to approve human clinical drug trials without mandatory animal testing.

    Article  CAS  PubMed  Google Scholar 

  3. Yang, Q., Fang, J., Lei, Z., Sluijter, J. P. G. & Schiffelers, R. Repairing the heart: state-of the art delivery strategies for biological therapeutics. Adv. Drug Deliv. Rev. 160, 1–18 (2020). A review article that summarizes the use of mRNA therapeutics for cardiac repair.

    Article  CAS  PubMed  Google Scholar 

  4. Huebsch, N. et al. Metabolically driven maturation of human-induced-pluripotent-stem-cell-derived cardiac microtissues on microfluidic chips. Nat. Biomed. Eng. 6, 372–388 (2022). This paper reports that geometrically aligned human cardiac microtissues on a chip reduce cell-phenotype-dependent variabilities in action potential and calcium handling of cardiomyocytes.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Zhao, S. et al. Acid-degradable lipid nanoparticles enhance the delivery of mRNA. Nat. Nanotechnol. 19, 1702–1711 (2024). This paper presents lipids with an acid-degradable linker termed ‘azido-acetal’ that hydrolyses within minutes of entering endosomes and enables the production of highly effective LNPs.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Neiman, G. et al. A microphysiological system for screening lipid nanoparticle−mRNA complexes predicts in vivo heart transfection efficacy. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-025-01523-4 (2025).

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

A modified nanoparticle–mRNA complex for improved gene editing in the heart. Nat. Biomed. Eng (2025). https://doi.org/10.1038/s41551-025-01559-6

Download citation

  • Published:

  • Version of record:

  • DOI: https://doi.org/10.1038/s41551-025-01559-6